Skip to main content

Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Publisher: Bentham Science Publishers

Volume 3, Number 1, February 2007

Addendum

Author Index Volume-2
pp. i-ii(2)
Author: Publishers

Favourites:
ADD

Subject Index Volume-2
pp. iii-vii(5)
Author: Publishers

Favourites:
ADD

Articles

MET and RON Receptor Tyrosine Kinases: Novel Therapeutic Targets in Squamous Cell Carcinoma of the Head and Neck
pp. 1-12(12)
Authors: Rogers, Susanne J.; Box, Carol; Nutting, Christopher M.; Rhys Evans, Peter; Harrington, Kevin J.; Eccles, Suzanne A.

Favourites:
ADD
Favourites:
ADD

Trypanosomatidae Peptidases: A Target for Drugs Development
pp. 19-48(30)
Authors: Beatriz Vermelho, Alane; Giovanni De Simone, Salvatore; Masini d'Avila-Levy, Claudia; Luis Souza do Santos, Andre; Cristina Nogueira de Melo, Ana; Paes Silva, Floriano; Pinto da Silva Bon, Elba; Helena Branquinha, Marta

Favourites:
ADD

Aldose Reductase in the Retina
pp. 49-60(12)
Author: Ahmed Mansour, Mahmoud

Favourites:
ADD

Selective Inhibition of Animal DNA Polymerases by Fat-Soluble Vitamins A,D, E and K and Their Related Compounds
pp. 61-75(15)
Authors: Mizushina, Yoshiyuki; Yonezawa, Yuko; Yoshida, Hiromi

Favourites:
ADD

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more